Citadel Advisors - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 102 filers reported holding IRADIMED CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$777,851
-51.9%
17,531
-48.3%
0.00%
Q2 2023$1,617,288
-21.4%
33,877
-35.2%
0.00%
Q1 2023$2,056,431
+380.0%
52,260
+245.1%
0.00%
Q4 2022$428,452
+70.0%
15,145
+169.6%
0.00%
Q1 2022$252,000
+5.9%
5,617
-20.7%
0.00%
Q3 2021$238,000
-11.9%
7,086
-43.8%
0.00%
Q3 2020$270,000
-50.9%
12,610
-46.9%
0.00%
Q2 2020$550,000
+28.5%
23,728
+18.4%
0.00%
Q1 2020$428,00020,0460.00%
Other shareholders
IRADIMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders